675 related articles for article (PubMed ID: 14979885)
1. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
Stillman MJ; Zajac D; Rybicki LA
Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
[TBL] [Abstract][Full Text] [Related]
2. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
Tanen DA; Miller S; French T; Riffenburgh RH
Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
4. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
5. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
8. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
9. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
Alemdar M; Pekdemir M; Selekler HM
Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
[TBL] [Abstract][Full Text] [Related]
10. Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels.
Lenaerts M; Bastings E; Sianard J; Schoenen J
Acta Neurol Belg; 1996 Jun; 96(2):126-9. PubMed ID: 8711985
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
Waberzinek G; Marková J; Mastík J
Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
[TBL] [Abstract][Full Text] [Related]
12. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
13. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine.
Reiter PD; Nickisch J; Merritt G
Headache; 2005; 45(7):899-903. PubMed ID: 15985107
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
17. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
18. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
19. Individualizing treatment with verapamil for cluster headache patients.
Blau JN; Engel HO
Headache; 2004; 44(10):1013-8. PubMed ID: 15546265
[TBL] [Abstract][Full Text] [Related]
20. Divalproex sodium in the treatment of migraine and cluster headaches.
Gallagher RM; Mueller LL; Freitag FG
J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
